The global label-free detection market is projected to reach USD 706.5 million by 2028, growing at a CAGR of 7.4%. High sensitivity of label-free technologies, introduction of scientifically advanced products and growing spending on research and development by biotech and pharmaceutical companies are some of the factors driving the growth of the global label-free detection market.

Adroit Market Research report on global Label-free detection market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global label-free detection market have been studied in detail.

The global label-free detection market is categorized based on product, technology, application and end user. On the basis of product, the market is segmented into instruments and consumables. The consumables segment dominated the market in 2020. On the basis of technology, the market is segmented into surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment dominated the market in 2020. On the basis of application, the market is segmented into binding kinetics, hit confirmation, lead generation, endogenous receptor detection, binding thermodynamics and other applications. On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs), and other end users. The pharmaceutical & biotechnology companies segment dominated the market in 2020.

North America dominated the market for label-free detection in 2020, while Asia Pacific set to grow at a highest CAGR due to increasing research activities in drug discovery and development. Key players of the global label-free detection market include Bio-Rad Laboratories, Bioptix, General Electric, Attana, Corning, Inc., Ametek, Inc., Pall Corporation, X-body Biosciences, Danaher Corporation, Roche Diagnostics among others.

Key segments of the global label-free detection market

Product Overview, 2018-2028 (USD Million)

• Instruments
• Consumables

Technology Overview, 2018-2028 (USD Million)

• Surface plasmon resonance
• Bio-layer interferometry
• Differential scanning calorimetry
• Isothermal titration calorimetry
• Other label-free detection technologies

Application Overview, 2018-2028 (USD Million)

• Binding kinetics
• Hit confirmation
• Lead generation
• Endogenous receptor detection
• Binding thermodynamics
• Other applications

End User Overview, 2018-2028 (USD Million)

• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Contract research organizations
• Other end users

 Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
• Middle East & Africa